1st Merchants Corp sold 2,182 shares of Edwards Lifesciences, reducing its stake to 74,852 shares.
1st Merchants Corp sold 2,182 shares of Edwards Lifesciences, reducing its holding to 74,852 shares. The institutional investor's holdings in Edwards Lifesciences were valued at $5,707,000. Several other hedge funds and institutional investors also made changes to their positions in EW. Vanguard Group Inc. increased its stake by 0.6%, and Nordea Investment Management AB raised its position by 1,224.1%.
April 07, 2024
9 Articles